메뉴 건너뛰기




Volumn 920, Issue , 2000, Pages 274-284

Prevention and reduction of AD-type pathology in PDAPP mice immunized with Aβ1-42

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN 1-42; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

EID: 0034535045     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06936.x     Document Type: Conference Paper
Times cited : (52)

References (9)
  • 1
    • 0021271971 scopus 로고
    • Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease
    • (1984) Neurology , vol.34 , pp. 939-944
    • McKhann, G.1    Drachman, D.2    Folstein, M.3
  • 3
    • 16044373524 scopus 로고    scopus 로고
    • Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
    • (1996) Nat. Med. , vol.2 , pp. 864-870
    • Scheuner, D.1    Eckman, C.2    Jensen, M.3
  • 7
    • 15644363081 scopus 로고    scopus 로고
    • High cerebrospinal fluid tau and low amyloid β 42 levels in the clinical diagnosis of Alzheimer's disease and relation to apolipoprotein E genotype
    • (1998) Arch. Neurol. , vol.55 , pp. 937-945
    • Galasko, D.1    Chang, L.2    Motter, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.